Apr 01, 2019 |
OncoCyte Provides Corporate Update and Reports Fourth Quarter and Full Year 2018 Financial Results
|
PDF
|
Apr 01, 2019 |
OncoCyte to Present Late Breaking Abstract at the American Thoracic Society 2019 International Conference
|
PDF
|
Mar 25, 2019 |
OncoCyte to Report Fourth Quarter and Full-Year 2018 Financial Results on Monday, April 1, 2019
|
PDF
|
Mar 06, 2019 |
OncoCyte Corporation to Present at Cowen and Company 39th Annual Health Care Conference in Boston
|
PDF
|
Mar 04, 2019 |
OncoCyte Announces Initiation of Analytical Validation Study
|
PDF
|
Feb 12, 2019 |
OncoCyte Announces Closing of Public Offering of Common Stock
|
PDF
|
Feb 08, 2019 |
OncoCyte Announces Pricing of Public Offering of Common Stock
|
PDF
|
Feb 07, 2019 |
OncoCyte Announces Proposed Public Offering of Common Stock
|
PDF
|
Jan 29, 2019 |
OncoCyte Announces Successful Results of DetermaVu™ R&D Validation Study
|
PDF
|
Jan 28, 2019 |
OncoCyte Schedules Announcement and Conference Call to Discuss Results from Key R&D Validation Study of DetermaVu™
|
PDF
|